First Multiple Sclerosis Biosimilar Approved

(MedPage Today) -- The first biosimilar for multiple sclerosis (MS) was approved, the FDA announced late Thursday. Natalizumab-sztn (Tyruko) was approved as a biosimilar to natalizumab (Tysabri) injection to treat clinically isolated syndrome...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news